LeafNLP Demos
Back to explore

Report #2887732

Received Mar 5, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
68 yrs
State
—
Recovered
Unknown
Vaccinated
Feb 15, 2026
Onset
Feb 15, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNK—

Symptoms (1)

Nausea

Symptom narrative

Intermittent nausea; This non-serious case was reported by a consumer and described the occurrence of nausea in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose taken on 23-OCT-2025.). Concurrent medical conditions included polycythemia vera. Concomitant products included hydroxycarbamide (Hydroxyurea). On 15-FEB-2026, the patient received the 2nd dose of Shingrix. On 15-FEB-2026, less than a day after receiving Shingrix, the patient experienced nausea (Verbatim: Intermittent nausea). The outcome of the nausea was unknown. It was unknown if the reporter considered the nausea to be related to Shingrix. It was unknown if the company considered the nausea to be related to Shingrix. Additional Information: GSK receipt date 23-FEB-2026 The patient self-reported the case. The symptoms were not treated. The batch number was not provided and a request for this information has been made.

Current illness

Polycythemia vera

Other medications

HYDROXYUREA